183 related articles for article (PubMed ID: 27678206)
1. Clinical and genetic investigation of a Brazilian family with Huntington's disease.
Agostinho LA; Spitz M; Pereira JS; Paiva CL
Funct Neurol; 2016; 31(3):135-42. PubMed ID: 27678206
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genetic characteristics in patients with Huntington's disease from China.
Yang J; Chen K; Wei Q; Chen Y; Cao B; Burgunder JM; Shang HF
Neurol Res; 2016 Oct; 38(10):916-20. PubMed ID: 27483361
[TBL] [Abstract][Full Text] [Related]
3. Haplotype analysis of the CAG and CCG repeats in 21 Brazilian families with Huntington's disease.
Agostinho Lde A; Rocha CF; Medina-Acosta E; Barboza HN; da Silva AF; Pereira SP; da Silva Idos S; Paradela ER; Figueiredo AL; Nogueira Ede M; Alvarenga RM; Hernan Cabello P; dos Santos SR; Paiva CL
J Hum Genet; 2012 Dec; 57(12):796-803. PubMed ID: 23051704
[TBL] [Abstract][Full Text] [Related]
4. The neurology and natural history of patients with indeterminate CAG repeat length mutations of the Huntington disease gene.
Panegyres PK; Goh JG
J Neurol Sci; 2011 Feb; 301(1-2):14-20. PubMed ID: 21147489
[TBL] [Abstract][Full Text] [Related]
5. Internal consistency of a Brazilian version of the unified Huntington's disease rating scale.
Tumas V; Camargos ST; Jalali PS; Galesso Ade P; Marques W
Arq Neuropsiquiatr; 2004 Dec; 62(4):977-82. PubMed ID: 15608955
[TBL] [Abstract][Full Text] [Related]
6. Clinical manifestations of intermediate allele carriers in Huntington disease.
Cubo E; Ramos-Arroyo MA; Martinez-Horta S; Martínez-Descalls A; Calvo S; Gil-Polo C;
Neurology; 2016 Aug; 87(6):571-8. PubMed ID: 27402890
[TBL] [Abstract][Full Text] [Related]
7. Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.
Podvin S; Reardon HT; Yin K; Mosier C; Hook V
J Neurol; 2019 Mar; 266(3):551-564. PubMed ID: 29956026
[TBL] [Abstract][Full Text] [Related]
8. A Study of Triplet-Primed PCR for Identification of CAG Repeat Expansion in the HTT Gene in a Cohort of 503 Indian Cases with Huntington's Disease Symptoms.
Chheda P; Chanekar M; Salunkhe Y; Dama T; Pais A; Pande S; Bendre R; Shah N
Mol Diagn Ther; 2018 Jun; 22(3):353-359. PubMed ID: 29619771
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Huntington's disease gene CAG trinucleotide repeat alleles in patients with bipolar disorder.
Ramos EM; Gillis T; Mysore JS; Lee JM; Alonso I; Gusella JF; Smoller JW; Sklar P; MacDonald ME; Perlis RH
Bipolar Disord; 2015 Jun; 17(4):403-8. PubMed ID: 25726852
[TBL] [Abstract][Full Text] [Related]
10. [Clinical picture of patients with Huntington's disease in relation to the number of trinucleotide CAG repeats in IT-15 gene].
Zielonka D; de Mezer M; Niezgoda A; Reperowicz K; Krzyzosiak W; Kozubski W
Neurol Neurochir Pol; 2002; 36(5):903-9. PubMed ID: 12523115
[TBL] [Abstract][Full Text] [Related]
11. Huntington's Disease: Relationship Between Phenotype and Genotype.
Sun YM; Zhang YB; Wu ZY
Mol Neurobiol; 2017 Jan; 54(1):342-348. PubMed ID: 26742514
[TBL] [Abstract][Full Text] [Related]
12. Uncovering the Genetic and Molecular Features of Huntington's Disease in Northern Colombia.
Ahmad M; Ríos-Anillo MR; Acosta-López JE; Cervantes-Henríquez ML; Martínez-Banfi M; Pineda-Alhucema W; Puentes-Rozo P; Sánchez-Barros C; Pinzón A; Patel HR; Vélez JI; Villarreal-Camacho JL; Pineda DA; Arcos-Burgos M; Sánchez-Rojas M
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003344
[TBL] [Abstract][Full Text] [Related]
13. Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.
Fusilli C; Migliore S; Mazza T; Consoli F; De Luca A; Barbagallo G; Ciammola A; Gatto EM; Cesarini M; Etcheverry JL; Parisi V; Al-Oraimi M; Al-Harrasi S; Al-Salmi Q; Marano M; Vonsattel JG; Sabatini U; Landwehrmeyer GB; Squitieri F
Lancet Neurol; 2018 Nov; 17(11):986-993. PubMed ID: 30243861
[TBL] [Abstract][Full Text] [Related]
14. Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease.
Zappacosta B; Monza D; Meoni C; Austoni L; Soliveri P; Gellera C; Alberti R; Mantero M; Penati G; Caraceni T; Girotti F
Arch Neurol; 1996 Jun; 53(6):493-7. PubMed ID: 8660149
[TBL] [Abstract][Full Text] [Related]
15. Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease-affected families.
Apolinário TA; da Silva IDS; Agostinho LA; Paiva CLA
Mol Genet Genomic Med; 2020 Apr; 8(4):e1181. PubMed ID: 32067426
[TBL] [Abstract][Full Text] [Related]
16. The Danish HD Registry-a nationwide family registry of HD families in Denmark.
Gilling M; Budtz-Jørgensen E; Boonen SE; Lildballe D; Bojesen A; Hertz JM; Sørensen SA
Clin Genet; 2017 Sep; 92(3):338-341. PubMed ID: 28155235
[TBL] [Abstract][Full Text] [Related]
17. Age of Onset of Huntington's Disease in Carriers of Reduced Penetrance Alleles.
McDonnell EI; Wang Y; Goldman J; Marder K
Mov Disord; 2021 Dec; 36(12):2958-2961. PubMed ID: 34536046
[TBL] [Abstract][Full Text] [Related]
18. Exploring the correlates of intermediate CAG repeats in Huntington disease.
Ha AD; Jankovic J
Postgrad Med; 2011 Sep; 123(5):116-21. PubMed ID: 21904093
[TBL] [Abstract][Full Text] [Related]
19. Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.
Moss DJH; Pardiñas AF; Langbehn D; Lo K; Leavitt BR; Roos R; Durr A; Mead S; ; ; Holmans P; Jones L; Tabrizi SJ
Lancet Neurol; 2017 Sep; 16(9):701-711. PubMed ID: 28642124
[TBL] [Abstract][Full Text] [Related]
20. The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease.
Klempíř J; Zidovská J; Stochl J; Ing VK; Uhrová T; Roth J
Mov Disord; 2011 Jan; 26(1):125-9. PubMed ID: 21322024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
